ANTRECTOMY WITH LAPAROSCOPIC ROUX Y RECONSTRUCTION FOR GIST OF LOWER GASTRIC CURVATURE
Main Article Content
Abstract
Gastrointestinal stromal tumors (GIST) are the most common mesodermal tumors of the gastrointestinal tract 70-80%. Originating from the interstitial cells of Cajal, due to oncogenic mutations in cKIT / CD117 and PDGFRA (85-90%), GISTs without controller mutations in KIT or PDGFRA have traditionally been grouped as wild-type GIST KIT / PDGFRA “wild type GIST” and within these there are molecular subgroups. They are usually asymptomatic, their most frequent location: Gastric (55.6%). Laparoscopic resection is the method of choice for its resection. It is described that the surgical approach is indicated in tumors> 2cm (<2cm endoscopic follow-up). The biological behavior of the same will depend on the size, immunohistochemistry and number of mitoses in 50 fields of high power (histopathological) Imatinib is a drug with inhibitory activity of tyrosine kinase receptors approved by the FDA in 2002 for the treatment of metastatic disease
Downloads
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. El-Menyar A. Diagnosis and management of gastrointestinal stromal tumors: An up-to-date literature review. Journal of Cancer Research and Therapeutics 2017; 13:889-900.
2. Ulrich Ronellenfitsch. Surgery for Gastrointestinal Stromal Tumors: State of the Art of Laparoscopic Resection and Surgery for M1 Tumors. Visceral medicine.2018
3. Joshua K. Kays. Approach to wild-type gastrointestinal stromal tumors. Translational Gastroenterology and Hepatol 2018; 3:92.
4. Eric C.H. Lai. Current management of gastrointestinal stromal tumors - a comprehensive review. International Journal of Surgery 10 (2012) 334-340.
5. Kjetil Søreide. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiology 40 (2016) 39–46.
6. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology– Soft Tissue Sarcoma. Version 2.2018. www.nccn.org/professionals/physician_ gls/pdf/sarcoma.pdf
7. Marcelo de Paula Loureiro. Laparoscopic resection of gastrointestinal stromal tumors (GIST). ABCD Arq Bras Cir Dig 2016; 29(1):1-4.
8. Juan Correa-Cote. Laparoscopic management of gastric gastrointestinal stromal tumors. World Journal of Gastrointestinal Endoscopy 2014 July 16; 6(7): 296-303.
9. Sebastian Huss MD. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations inKIT/PDGFRA wild-type GISTs are rare events. Human Pathology (2017) 62, 206–214.
10. Peter J. Oppelt. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. Journal of Gastrointestinal Oncology Vol 8, No 3 June 2017.
11. Casali et al.Gastrointestinal stromal tumours: ESMO– EURACANClinical Practice Guidelines for diagnosis, treatmentand follow-up. Annals of Oncology 0 (Supplement 0): iv1–iv11, 2018.